<DOC>
	<DOCNO>NCT01568424</DOCNO>
	<brief_summary>The study objective gather post-market clinical data use CentriMag RVAS use temporary mechanical circulatory support right ventricle patient acute right ventricular failure cause</brief_summary>
	<brief_title>CentriMag RVAS U.S. Post-approval Study Protocol</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Right ventricular failure cause Primary coagulopathy platelet disorder Allergy sensitivity heparin alternative anticoagulant</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Right Ventricular Failure</keyword>
	<keyword>Levitronix</keyword>
</DOC>